EGW-Newsminiature joined Susquehanna Soniqs
miniature joined Susquehanna Soniqs
5679
Add as a Preferred Source
0
0

miniature joined Susquehanna Soniqs

The North American esports organization Susquehanna Soniqs has announced changes to the VALORANT starting roster, inviting miniatures for a trial period. The 23-year-old American esportsman will replace dizzyLife, who was transferred to the bench.

miniature entered the professional scene in 2020 by joining Morning Light. Already in September, the player moved to Elevate, with whom he spent the rest of the period until January 2022. During this time, the 23-year-old American esportsman won Valorant Sunday Showdown Week 68, and also made it to the top three at Valorant Sunday Showdown Week 41, Valorant Sunday Showdown Week 47, NSG: Summer Championship - Open 5, Knights Monthly Gauntlet - August and PlayerzZone Invitational.

Chicken.gg
Free gems, plus daily, weekly, & monthly boosts!
Chicken.gg
CS:GO
Claim bonus
Bulldrop Vip
egw - get 20% Deposit Bonus
Bulldrop Vip
Claim bonus
Skinbattle.gg
Best odds, Best Rewards, Daily Cases +5% deposit bonus
Skinbattle.gg
Claim bonus
CsMoney
CS2: Get skins cheaper than on Steam
CsMoney
Claim bonus
GGDrop
egwnew- gives +11% to the deposit and free spin on the bonus wheel
GGDrop
CS:GO
Claim bonus

In turn, dizzyLife has been playing for Susquehanna Soniqs since April last year. During this time, the Australian esportsman won with the team Knights Monthly Gauntlet - April, NSG: Summer Championship - Open 8 and BoomTV Proving Grounds #2, and also reached the final at NSG: Summer Championship - Monthly April, Knights Monthly Gauntlet - June and Rival Room - Rival 1.

Don’t miss esport news and update! Sign up and recieve weekly article digest!
Sign Up

From now on, the composition of Susquehanna Soniqs is as follows:

  • Bob.
  • IyeN.
  • Crunchy.
  • JSUNG.
  • miniature (trial period).
  • x0tek (coach).
Leave comment
Did you like the article?
0
0

More about teams:

SoniqsSoniqsEGW

Comments

FREE SUBSCRIPTION ON EXCLUSIVE CONTENT
Receive a selection of the most important and up-to-date news in the industry.
*
*Only important news, no spam.
SUBSCRIBE
LATER
We use cookies to personalise content and ads, to provide social media features and to analyse our traffic.
Customize
OK